Effect of donor/recipient sex on death among patients who underwent transplantation for CML, AML, and ALL
. | Adjusted hazard ratio* . | 95% CI . | P . |
|---|---|---|---|
| CML | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 1.61 | 1.30-1.99 | < .0001 |
| AML | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 1.22 | 1.03-1.45 | .02 |
| ALL | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 1.18 | 0.97-1.44 | .09 |
. | Adjusted hazard ratio* . | 95% CI . | P . |
|---|---|---|---|
| CML | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 1.61 | 1.30-1.99 | < .0001 |
| AML | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 1.22 | 1.03-1.45 | .02 |
| ALL | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 1.18 | 0.97-1.44 | .09 |
NA indicates not applicable.
Adjusted for patient and donor age, GVHD prophylaxis, disease status, conditioning regimen, and patient/donor CMV serostatus.